The program is entirely online, allowing users to complete assessments, consult with licensed providers, and receive medications delivered discreetly to their homes

As of April 2026, Zepbound (tirzepatide) appears on the formulary with the following restrictions: Covered indications: Type 2 diabetes mellitus as an adjunct to diet and exercise Must be prescribed by a TRICARE-authorized provider Requires prior authorization regardless of plan type Subject to step therapy requirements (metformin, sulfonylureas, or other first-line agents must be tried first) Excluded indications: Obesity or weight management in patients without type 2 diabetes Overweight status (BMI 25 to 29.9) Metabolic syndrome without diagnosed diabetes Prediabetes (HbA1c 5.7% to 6.4%) Cardiovascular risk reduction in non-diabetic patients The distinction matters because Zepbound is FDA-approved for both chronic weight management (approved December 2023) and type 2 diabetes (approved May 2022 under the brand name Mounjaro)
Why Choose Eden Health Club
or better yet, consult a board-certified dermatologist about proven alternatives
Hormonal changes may contribute to low libido in some women and men, but sexual health can also be affected by stress, sleep, medications, relationships, mental health and other medical factors
What is the expected timeline